Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox to $132 from $136 and keeps an Underweight rating on the shares post the fiscal Q3 report. The firm thinks the investment debate will continue to shift towards Clorox’s long-term revenue growth ambitions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox reports Q3 gross margin up 40 bps to 42.2% from 41.8% last year
- Clorox Releases Insightful Supplemental Financial Data
- Clorox Reports Q3 Fiscal Year 2024 Results, Updates Outlook
- Clorox raises FY24 adjusted EPS view to $5.80-$5.95 from $5.30-$5.50
- Clorox reports Q3 adjusted EPS $1.71, consensus $1.37